Vitreomacular Adhesion Including Macular Hole Completed Phase 3 Trials for Ocriplasmin (DB08888)
| Indication | Status | Phase |
|---|---|---|
| DBCOND0054364 (Vitreomacular Adhesion Including Macular Hole) | Completed | 3 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT01429441 | Ocriplasmin for Treatment for Symptomatic Vitreomacular Adhesion Including Macular Hole | Treatment |